US panel backs COVID-19 pill from Merck

By Matthew Perrone
Updated December 1 2021 - 9:10am, first published 9:05am
The US FDA is expected to make its decision on Merck's COVID-19 pill before year's end.
The US FDA is expected to make its decision on Merck's COVID-19 pill before year's end.

A panel of US health advisers has narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorisation of the first drug that Americans could take at home to treat the virus.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Gloucester news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.